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ABASTRACT:
Introduction: Myasthenia gravis (MG) is the most common acquired autoimmune disorder of 
neuromuscular transmission. It has different patterns of presentation.
Objective: to study the pattern and mode of presentation of Myasthenia Gravis in Al-Shaab and 
Omdurman Teaching Hospitals, Khartoum Sudan.
Methods: The demographic and clinical characteristics of 50 patients of myasthenia gravis (MG) 
were reviewed in Alshab and Oumdrman Teaching Hospitals for five months period from May to 
October 2008.
Results: Out of 2400 patients attending neurology clinics 50 were found to have Myathenia Gravis 
[MG] with female; male ratio of 2.5:1. The age at presentation was the second decade of life in 
34%. Most of the patients [42%] were from Khartoum State followed by North Kordofan State 
[14%]. High occurrence of late onset fatigability and weakness was seen in 92 % of our patients.   
Ocular muscles involvement was detected in 78%. MG was aggravated by hot weather and fever in 
12% of the patients. Quinine represented the most common drug which aggravated the myasthenia 
symptoms in 4%. Diabetes mellitus and thyroid diseases were the most associated auto immune 
diseases seen in 12% and 4 % respectively. The diagnosis was made by classic history and 
neurological examinations in 88% and positive neostigmin test in64%. The majority of patients 
were treated with steroids. Thymectomy was done in 10% patients. The outcome was excellent as 
82% improved and only one [2%] patient died. 
Discussion: Going with literature diagnosis of MG was made depending on classical history, full 
neurological examination and confirmed by tensilon test. Because of different reasons more 
sophisticated tests were not done in our patients. Only patients with malaria who were treated with 
quinine showed deterioration of their symptoms in our study. Strikingly, myasthenia crisis which 
were reported in 27% of patients were not seen in our population. Because of lack of usage of 
steroid sparing agents the vast majority [96%] of our patients were treated with steroids.
Conclusion:
Generalized myasthenia gravis with ocular involvement is common in our patients. However, pure 
OMG was not seen. Thymectomy was done in a small number of our patients with reference to 
other studies.
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yasthenia gravis (MG) is the most 
common acquired autoimmune 
disorder of neuromuscular 
transmission. The hallmark of MG is 
fluctuating weakness, fatigability of skeletal, 
ocular, bulbar and respiratory muscles. 
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The fatigue is manifested by worsening 
contractile force of muscles due to an 
antibody mediated T-cell dependant 
immunological attack. The attack is directed 
at proteins in post-synaptic membrane of the 
neuromuscular junction. MG can be classified 
into two groups: ocular myasthenia gravis 
(OMG) and generalized myasthenia gravis 
(GMG).
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In OMG the weakness is limited to the eyelids 
and extra- ocular muscles. In GMG the 
weakness involves a variable combination of 
bulbar, limbs and respiratory muscles in 
addition to affections of ocular muscles. 
When antibodies to acetylcholine receptors 
(AchRAb) are detected the disease is called 
seropositive myasthenia gravis (SPMG). 
About half of the patients with pure ocular 
OMG are seropositive compared with four-
fifth of those with GMG. 10-20% of patients 
with MG have an underlying thymoma
١
.
Objective of the study:
The objective is to study the pattern and mode 
of presentation of myasthenia gravis in Al-
Shaab and Omdurman Teaching Hospitals 
Khartoum Sudan.
Research methods: 
This is a cross sectional hospital based 
descriptive retrospective study. It was 
conducted at Al-Shaab and Omdurman 
Teaching Hospitals during the period from 
May to October 2008. All patients attending 
neurology clinics were seen and the targeted 
patients were selected. Only the patients who 
were confirmed to have MG and whose ages 
were above 16 years were selected.
The patients were consented about the study 
and each patient was interviewed. Files of the 
patients were retrieved and questionnaires that 
contain information about the personal data, 
presentation, aggravating factors, associated 
autoimmune diseases, diagnostic tools, 
treatment and the outcome were filled. The 
data were analyzed and discussed.   
The result;
Out of 2400 patients attending neurology 
clinics in the period of May to October 2008; 
50 were confirmed to have MG.  Females 
were 36 [72%]; the majority 36 (72%) of the 
patients were singles. The patients presenting 
in the first decade of life constituted 10% of 
the total number (Fig.1). It was found that 21 
[42%] of the patients were from Khartoum 
states while the rest were from other parts of 
Sudan. The Late onset of weakness and 
fatigability occurred in 92% of patients 
(table1). Bilateral ocular muscles involvement 
was seen in all 39 of the patients who 
developed eye symptoms.
 Fig 1 Age distribution
Table 1
Diplopia and ptosis were found in 36 and 34   
patients respectively. The duration of ocular 
muscle involvements before presentations 
was less than two month in12% of patients 
while difficulty in walking was seen in 84% 
(table 2).       
 Shortness of breath was found in only 6 
[12%] and was mild in severity. The 
symptoms were progressive in 34 [64%], 
fluctuating in 14 [28%] and static in 2[4%] 
patients. Symptoms were aggravated by hot 
weather in 12% of patients (table3). Apart 
from two [4%] patients who had thyroid 
disease and six [12%] who had type 2 
diabetes; no other autoimmune disease was 
detected.  Patients were diagnosed by 
classical history in 88% (table4).  
Thymectomy was performed in five [10%] 
while the rest had only drugs. Improvement 
occurred in41 [82%], eight [16%] remain 
static and one [2%] patient died.
Presentation Frequency (%)
Late weakness 46(92)
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Table2
N=number. Du= duration. OI=Ocular Involvement. NR=Nasal Reg. AS=AbnormalSpeech. 
BO=BilatralOcular. Di=Diplopia. Pt= Ptosis. W=Walking. Pr=Praying. R=Running. Ch=Chocking. 
SOB= Shortness of breath
Discussion: 
Myasthenia gravis is the most 
common understood autoimmune disease.  It 
is relatively common; however the prevalence 
in Sudan is not studied. In Egypt MG 
prevalence is about 9.57 per 100.000 while in 







The prevalence of the disease has 
increased over the last five decades because 
of good recognition of the disease, aging of 
the population and the longer life span of the 
Going with literature diagnosis of MG was 
made depending on classical history and full 





In some other studies AchR-Ab assays
4
 which 
were found to be more specific and sensitive 
tests were also added
5
. However, somewhere 
repetitive nerves stimulation and single fiber 
electro- myography were found even more 
sensitive and more specific 
6, 7
.  Because of 
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done in our patients. A large number of our 
patients (42%) were from Khartoum State. 
This is probably because of the large 
movements of the population from other 
states to the capital in the last years. In MG 
there is a trend to have a bimodal distribution 
to the age of onset with early peak in the 
second-third decades where females 
predominate and a late peak in the sixth-
eights decades with male predominance
1
. In 
our study we found no bimodal distribution of 
age. Different reports have different age-sex 
distributions
8, 9
. In a study done in Libya they 
found that female to male ratio was 2.6:1 
similar to our finding
3
.  Bilateral ocular signs
and diplobia were seen in 78% and 72% of 
our patients respectively which are similar to 
the 73.5% and 85% reported somewhere
10
. 
However, none of our patients had presented 
with pure ocular MG. Matching with that; 
GMG was detected in 94.5% of the patients in 
Libya. This is different from reports from Dar 
Elsalam and elsewhere
11, 12
.  These 
differences are probably due to the 
complexity and variable mode of 
presentations that characterize MG. Early in 
the course of the disease the symptoms are 
usually fluctuant and may be transient. 
However, the maximum extent of weakness 
occurs in 77-82% of patients within two to 
three years. This is probably the reason for the 
delay of 2.5 years between appearance of 
symptoms and diagnosis.  Most of our 
patients had presented within one year of the 
onset of symptoms.  This is likely because a 
large number of our patients were from 
Khartoum State where the specialized 
neurology facility is available. Nevertheless, 
negligence of the early signs of MG might 
have also contributed to that
13, 14
.
Diabetes mellitus and thyroid 
disorders [12% and 4%] were the only 
detected autoimmune diseases associated with 
MG in our population. This is less than the 
27% reported in literature. The lack of 
availability of other diagnostic tests might 
have contributed to that. MG was reported to 
be aggravated by different drugs and 
diseases
8, 10
. Only patients with malaria who 
were treated with quinine showed 
deterioration of their symptoms in our study. 
The relative role played by the malaria and 
quinine in that is difficult to determine. 
Strikingly, myasthenia crisis which were 
reported in 27% of patients were not seen in 
our population
15
. Unlike our patients, 
somewhere all patients received symptomatic 
treatment in a form of anti cholinesterase 
inhibitor. Only 22.2% of the patients in Libya 
study received steroids therapy compared to 
96% of our patients. The lack of usage of 
steroid sparing agents by our patients can 
partially explain that. Thymectomy was done 
in a small number of our patients with 
reference to other studies
3, 12
. This is probably 
because of the social fear of surgery and the 
different protocols of managements. The 
improvement in this study [82%] is consistent 
with the literature. The mortality rate was low 
in our patients compared to others’
16
. The 
small number of patients, being relatively 
young and have less thymoma might be 
behind that. 
Conclusion:
Generalized myasthenia gravis with ocular 
involvement is common in our patients. 
However, pure OMG was not seen. The 
bimodal age distribution of the disease is not 
seen in our population. Its association with 
other autoimmune diseases is not as common 
as in literature. Thymectomy and steroid 
sparing drugs were the least modes of 
treatment in our patients for different reasons. 
However, the outcome was excellent and 
myasthenia crisis were not reported. 
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